| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |